Abstract: Enoxaparin-immobilized gelatin/poly(ε-caprolactone) (PCL) or Eudragit ® RS230D nanogels in the presence of tetraethyl orthosilicate (TEOS) as polycondensation reagent were designed and characterized for their sustained drug delivery ability. Enoxaparin (anti-Xa 1000 UI/mL) was used as a model drug at different concentrations (300, 500, and 1000 UI/mL). The resulting nanogels were prepared using sol-gel technique and analyzed using several analytical tools such as: thermal analysis (DSC and TGA), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning and transmitting electron microscopes (SEM and TEM). In addition to particle size, zeta potential and in vitro release profiles were also investigated. A burst effect was observed, afterwards, the release rate became steady. The immobilization of enoxaparin into the gel network led to the formation of stable nanogels with ionic functional groups, which enable the efficient loading and sustainable release. The preliminary results showed that enoxaparin-immobilized PCL-based nanogels in this study can be utilized in the design of a sustained delivery system.
Introduction
Poly(ε-caprolactone), PCL, is a biocompatible and biodegradable polyester. Degradation of PCL in comparison to other polymers is slow, making it suitable for long-term delivery extending over a period of more than 1 year. The advantage of using PCL is that it does not generate an acid environment and provides support and structural stability in the host tissue. However, its cytocompatibility needs to be improved because its hydrophobicity retards cell attachment [1] . Sol-gel techniques have many advantages over traditional ones for manufacturing new materials. There are two approaches to the performance of the sol-gel process; the first variant is associated with the use of commercially available sols of Si-O 2 particles. The sol is destabilized by varying the acidity of the medium and the consecutive particles aggregation and their subsequent condensation lead to the formation of the silica gel [2] [3] [4] [5] [6] . The second approach involves the so-called organic sol-gel process [7] . Among different dosage forms, nanoparticles have been identified as a novel class of matrices possessing a great potential as drug carrier [8, 9] . Heparin, a highly sulfated glycosamineglycan, is widely used as an injectable anticoagulant, and has the highest charge density of any known biological molecule [10] . It is used clinically to minimize thrombus formation on artificial surfaces. However, heparin can sometimes cause undesirable acute and chronic complications. In the case of its parenteral administration, it has deleterious properties, especially during long-term outpatient therapy (pregnancy and cancer). In order to eliminate these complications, numerous approaches have been tested [11, 12] . Low-molecular-weight heparins (LMWHs) can be considered as high molecular hydrophilic polyanions [13] . Most of the currently available LMWH are depolymerized porcine mucosal heparin preparations, prepared by chemical or enzymatic digestion methods [14] . Their molecular size generally ranges from 3000 to about 12 000 Da. LMWHs are used to prevent blood clotting, so they could be used to treat superficial thrombosis [15] . There are some dosage forms already on the market, including Thrombophob ® gel in the USA and Lioton ® 1000 gel in Switzerland. The aim of this study is to prepare a hydrogel containing LMWH (enoxaparin) with proven permeation properties. The gel we proposed to develop is based on interactions between this polyanionic drug and Eudragit ® RS230D, a cationic polymethylmethacrylate copolymer grafted with trimethylammonioethyl methacrylate chloride in the presence of gelatin, TEOS and/or PCL using the sol-gel technique.
Experimental part Materials
Edible gelatin, Mw ∼40 000 (Gel) was purchased from Davis Gelatin NZ Limited, Christchurch, NZ. Poly(ε-caprolactone), PCL, and Eudragit ® RS230D (Eud), (copolymer of ethylacrylate, methyl methacrylate and a low content of a methacrylic acid ester with quaternary ammonium groups) were donated by SCPI, Beauvais, France. Tetraethyl orthosilicate (TEOS) was obtained from Sigma-Aldrich. Enoxaparin 
Methods

Preparation of the enoxaparin-loaded nanogels
The enoxaparin-containing TEOS samples were prepared by a two-step synthesis starting from the gelatin precursor (gel), PCL and/or Eudragit RS230D (Table 1) . First, the gelatin, PCL or Eudragit moieties were crosslinked by means of the sol-gel process, followed by photoinitiated radical polymerization of the amino groups as the second step. The sol-gel process was carried out under a dry nitrogen atmosphere with HCL as catalyst [16] . The molar ratio of the starting sol, gel:PCL or Eudragit:TEOS:HCL:H 2 O, ratio was 1:1:1:2:0.6. After hydrolysis (denaturation) of gel with water and the catalysis (∼2 h boiling under reflux condition) a colorless homogenous solution was obtained, to which different concentrations (300, 500, and 1000 UI/mL) of enoxaparin and 2.0 mmol of benzoinmethylether were then added. The sol was cast into plastic molds and kept at room temperature for polycondensation, ageing and drying for 3 days. For cross-linking of the organic matrix, the drug-loaded nanogel samples were exposed to ultraviolet (UV) light (150 W, XBO Xenon lamp, light spectrum 200-1100 nm) for 15 min. Sol-gel formation was conducted based on two mechanisms, hydrolysis, and condensations as follows:
Release of enoxaparin in vitro
The dissolution tests of enoxaparin release from the different nanogel matrices were carried out in a shaking water bath at 37 °C. The average weight of the samples was 2 g. Phosphate buffered saline (PBS) was used as dissolution medium [17] , because the composition of inorganic ions as well as the pH value are close to that of human blood plasma. PBS (pH 7.4) was freshly prepared by dissolving 8.0 g (137 mmol) of sodium chloride, 0.2 g (2.68 mmol) of potassium chloride, 1.11 g (9.10 mmol) of disodium hydrogen phosphate and 0.2 g (1.47 mmol) of potassium dihydrogen phosphate in 1 L of deionized water. Enoxaparin-loaded samples were immersed in 25 mL of PBS in a glass bottle and 1.0 mL aliquots of sample liquid were removed at scheduled times for enoxaparin quantification and replaced with fresh PBS. The total amount of dissolved enoxaparin was measured by the colorimetric toluidine blue method [18] . Different aliquots were used, such that the enoxaparin concentration was within the measurement range of the method. Three parallel samples were examined, each data point being the mean of three values.
Characterization
The IR spectra were recorded on a FTIR Perkin-Elmer spectrometer. The morphological features of unloaded and loaded-gel nanoparticles were studied using JEOL transmission electron microscope JEM-1230(TEM) and scanning electron microscope (SEM). Thermal analysis was carried out using Perkin-Elmer DSC and thermogravimetric analysis (TGA). The particle size and zeta potential (ξ) of the freshly produced nanogels were studied in the different buffer pH solutions (2.0, and 7.4) by means of a laser Doppler anemometer (Mastersizer S, Malvern Instruments, Orsay, France). Each sample was measured in triplicate.
Results and Discussion
Characterization of the prepared nanogels
The processing conditions of the sol-gel can be manipulated by changing the type and concentration of sol components to allow for sol-gels to be used for different detection methods [19] . Figures 1 and 2 show FTIR spectra of pure gelatin and the prepared nanogels (gel/Eud-Si and gel/PCL-Si) before and after enoxaparin loading. It was observed that the most intensive band at 1100 cm -1 is due to the stretching vibrations of the Si-O-Si bridges. A sharp peak is observed at 1272 cm -1 which corresponds to Si-C bonds for gel/PCL-Si and gel/PCL-Si/Enoxaparin. The presence of CH 3 asymmetric stretching vibration is supported by a sharp peak at 2979 cm -1 and a peak due to CH 3 asymmetric bend is observed at around 1420 cm -1 . This confirms the functionalization of the prepared nanogels by tetra ethylsilicate (TEOS). Table 1 shows the chemical compositions of the prepared nanogels. Table 2 shows TGA data of the prepared nanogels (gel/PCL-Si and gel/Eud-Si). The weight loss (%) starting from 103 °C up to 360 °C corresponds to the multi-step degradation and pyrolysis of the complex helical structure of gelatin to tropocollagen macromolecules [20] . Figure 3 shows DSC curves of the prepared nanogels (gel/PCL-P, gel/PCL-Si and gel/Eud-Si). Moreover, the heat flow data for the nonisothermal melting and crystallization is listed in Table 3 , including temperature of crystallization (T c °C), temperature of melting (T m °C), enthalpy of crystallization (ΔH c J/g), and enthalpy of melting (ΔH m J/g). As expected T c of PCL was significantly changed for Si-and P-based nanogels. Furthermore, the crystallinity of the PCL matrix was inhibited by addition of amorphous gelatin matrix. Ray et al. [21] proposed that only exfoliated silicate platelets are able to act as effective nucleating agents, thus causing the formation of smaller crystallites. PCL is a semi-crystalline polymer and the three peaks obtained between 2θ 20 and 30, correspond to d-spacing of 0.414, 0.374, and 0.325 nm and can be assigned as the 110, 111, and 200 crystal planes [22] . However, the prepared nanogels exhibit amorphous nature. The broad peak between 2θ 20-30 was attributed to amorphous silica. Moreover, the appearance of very weak peaks at 2θ 22.40, 24.22, 28.23 (which corresponds to the presence of silica-PCL and silica-Eudragit) was assigned to the monoclinic silica phase according to JCPDS cards no. 89-1813 (Fig. 4) . Consequently, the incorporation of gelatin, PCL, or Eudragit into the silicate system increases the chemical bonds in the network and decreases the crystallinty. An increase in basal spacing of PCL-based nanogel system was attributed by Chen et al. [23] to be equivalent to a monolayer of PCL molecules inserted within the inter-gallery spaces of the layered silicate. For the nanogels prepared in this study, the inter-gallery space expanded by more than two monolayers indicating that the PCL may have adopted a planar bi-layer conformation within the galleries. For these reasons, addition of gelatin and/or enoxaparin to the PCL-Si matrix also resulted in an increase in the d-spacing relative to the PCL and silicate matrices ( Table 4) . The mean particle size of the prepared nanogels before and after drug loading was measured. As expected, the results of the particle size of enoxaparin-loaded nanogels showed that the particle size was decreased to reach nearly colloidal stable particles after drug release. In other words, enoxaparin was completely released from the nanogels after 24 h. The zeta potential was investigated in order to determine the effect of pH on the surface charge density. The variation of the zeta potential versus pH values (2.0 and 7.4) was recorded in Table 5 . The magnitude of the zeta potential was found to be negative at pH 7.4, in case of the unloaded and loaded nanogels, while at low pH value (2.0), zeta potential was increased. The dramatic change in the zeta potential is predicted by the classical electrokinetic theory [24] . Moreover, the negative zeta potential may be attributed to the presence of carboxylic (gelatin), sulfated (enoxaparin) functions in the nanogel matrices, which carry predominantly free anionic groups on the chain ends. It can be concluded that the zeta potential decreases upon increasing the pH value which was attributed to the presence of high carboxylic amount and the coexistence of other negatively charged compounds. Figures 5 and 6 show SEM-micrographs of the prepared nanogels (gel/Eud-Si and gel/PCL-Si) before and after enoxaparin release. The morphology and extent of Si-with and without enoxaparin were observed. In the case of addition of enoxaparin to the nanocomposite matrix, the irregular enoxaparin particles were randomly dispersed in the matrix. After drug release, a different morphology was obtained which revealed smaller particles adsorbed on the surface. TEM images of the prepared nanogels (gel/Eud-Si and gel/PCL-Si) before and after enoxaparin released were illustrated in Fig. 7 . It can be observed that the prepared nanogels before and after enoxaparin release had stable colloidal particles. Table 5 Zeta potential (ζ mv) of the prepared nanogels as a function of pH (n = 3 ± SD).
Sample code
Zeta potential (ζ mv) at different pH values pH 2.0 pH 7.4
Gel/Eud-Si -1.03 -16.1 Gel/Eud-Si/enoxaparin -1.5 -2.5 Gel/PCL-Si -0.2 -2.8 Gel/PCL-Si/enoxaparin -1.9 -4.8 
In vitro enoxaparin release
The release of enoxaparin from all matrices with different compositions can be considered to follow firstorder kinetics during the dissolution period due to the finite nature of the drug store. The correlation between the drug concentrations and the respective release of enoxaparin from the differently drug-loaded samples is shown in Figs. 8 and 9 . The initial burst release from matrices is a well-known problem which is more evident for systems with higher surface area and increases when the molecular weight of heparin decreases and the amount of embedded heparin increases [25] . For all enoxaparin formulations, the release profiles could be divided in two phases: an initial burst followed by a plateau. However, the curves had different forms depending on the enoxaparin concentrations and the chemical composition of the nanogels. For enoxaparin concentration 1000 UI/mL, in case of gel/Eud-Si, a large and rapid burst (∼98 %) was observed during the first half-hour and was followed by a plateau leading to complete release at 24 h. While in case of gel/PCL-Si, the total amount released during the first half-hour was ∼78 %. On the other hand, in case of gel/Eud-Si (enoxaparin concentrations 300 and 500 UI/mL), the release was slower and more sustained than that of high enoxaparin concentration (1000 UI/mL). From these observations, at low concentrations, some enoxaparin chains were partly adsorbed on the surface of nanogels, leading to easy desorption and explaining the burst effect. On the other hand, other chains interacted strongly with Eudragit RS30D leading to their incomplete release. According to the previous report on heparin-loaded silica xerogels [26] , the release of heparin dispersed in an inorganic matrix occurs according to a combined process of diffusion of solvent through the capillarity channels and erosion of the matrix into non-toxic ionic products. It can be concluded that the amount of heparin embedded did not have an influence on the degradation rate of the matrix, which means that the different enoxaparin-loaded does not change the structure of the prepared nanogel matrices. Moreover, the release of enoxaparin is dependent on the composition of the formulation and its concentration. In future works, a further control of the release kinetics of different low-molecular-weight heparins (LMWHs) might be achieved by modification of the nanogel matrix with molecules that can bind covalently or ionically. In addition the biological activity of LMWHs-loaded samples will be investigated.
Conclusions
The novel drug delivery systems based on an organically modified tetraethyl orthosilicate (TEOS) with gelatin and PCL or acrylate copolymer (Eudragit) were successfully prepared using sol-gel technique. The prepared nanogels exhibited amorphous nature with stable colloidal particles (9.3 nm) and high surface charges denisty (negative zeta potentail). The release properties can be modified and adjusted according to therapeutic needs. The results demonstrated that drug release from the prepared nanogels can be controlled by using sol-gel technique. Moreover, the high amounts of drug embedded in the nanogel matrices should be a faster release profile. In other words, at high drug concentration (1000 UI/mL) a large and rapid burst release was observed during the first half-hour and was followed by a plateau leading to complete release at 24 h. While, at low drug concentrations (300 and 500 UI/mL), the release was slower and more sustained than that of high one.
